Biophysical Fragment Screening of the β 1 -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design
Journal of Medicinal Chemistry2013Vol. 56(9), pp. 3446–3455
Citations Over TimeTop 1% of 2013 papers
J.A. Christopher, Jason Brown, A.S. Dore, James C. Errey, Markus Koglin, Fiona H. Marshall, David G. Myszka, Rebecca L. Rich, Christopher G. Tate, Benjamin G. Tehan, Tony Warne, Miles Congreve
Abstract
Biophysical fragment screening of a thermostabilized β1-adrenergic receptor (β1AR) using surface plasmon resonance (SPR) enabled the identification of moderate affinity, high ligand efficiency (LE) arylpiperazine hits 7 and 8. Subsequent hit to lead follow-up confirmed the activity of the chemotype, and a structure-based design approach using protein-ligand crystal structures of the β1AR resulted in the identification of several fragments that bound with higher affinity, including indole 19 and quinoline 20. In the first example of GPCR crystallography with ligands derived from fragment screening, structures of the stabilized β1AR complexed with 19 and 20 were determined at resolutions of 2.8 and 2.7 Å, respectively.
Related Papers
- → Identification of the metabolites of benzo[f]quinoline and benzo[h]-quinoline formed by rat liver homogenate(1983)11 cited
- Synthesis of Mercaptoalkoxy quinoline Compounds(2002)
- → Synthesis of benzo[g]quinoline derivatives(1970)
- → Carcinogenic Activity of Analogues of <italic>p</italic>-Dimethylaminoazobenzene. IV. Activity of the Quinoline Analogues<xref ref-type="fn" rid="FN1">2</xref>(1961)